PAD4抑制剂GSK484通过抑制H3Cit表达减轻小鼠脓毒症肺损伤后内皮功能障碍的发生
目的 探讨PAD4抑制剂(GSK484)对脓毒症后H3Cit表达的抑制作用,并探究其对脓毒症引起的内皮功能障碍的改善效果.方法 C57BL/6小鼠18只通过盲肠结扎穿孔术(CLP)构建小鼠脓毒症模型,实验分为假手术组,模型组和GSK484治疗组,6只/组,治疗组在术后第2天腹腔注射给予GSK484(4mg/kg).ELISA检测小鼠血清VEGF、ESM-1、IL-6、IL-1β水平,HE染色观察肺组织病理学变化,免疫荧光和Western blotting检测各组小鼠肺组织中F-actin、VE-cadherin、ZO-1蛋白表达,Western blotting检测肺组织VE-Cadherin...
Saved in:
| Published in | 南方医科大学学报 Vol. 44; no. 12; pp. 2396 - 2403 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | Chinese |
| Published |
中南大学湘雅医学院附属长沙医院//长沙市第一医院急诊科,湖南长沙 410005%中南大学湘雅医学院附属长沙医院//长沙市第一医院全科医学科,湖南长沙 410005
2024
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1673-4254 |
| DOI | 10.12122/j.issn.1673-4254.2024.12.16 |
Cover
| Abstract | 目的 探讨PAD4抑制剂(GSK484)对脓毒症后H3Cit表达的抑制作用,并探究其对脓毒症引起的内皮功能障碍的改善效果.方法 C57BL/6小鼠18只通过盲肠结扎穿孔术(CLP)构建小鼠脓毒症模型,实验分为假手术组,模型组和GSK484治疗组,6只/组,治疗组在术后第2天腹腔注射给予GSK484(4mg/kg).ELISA检测小鼠血清VEGF、ESM-1、IL-6、IL-1β水平,HE染色观察肺组织病理学变化,免疫荧光和Western blotting检测各组小鼠肺组织中F-actin、VE-cadherin、ZO-1蛋白表达,Western blotting检测肺组织VE-Cadherin和H3Cit蛋白表达情况.肺组织原代分离培养肺微血管内皮细胞,使用脂多糖(LPS,10 μg/mL)干预24 h构建脓毒症模型.检测细胞成管能力,CCK-8检测细胞增殖,流式检测细胞凋亡,ELISA检测细胞上清中VEGF、ESM-1、IL-6、IL-1β水平.结果 与假手术组相比,脓毒症小鼠肺组织肺脏血管充血、肺泡断裂、肺泡腔及肺间质水肿、肺泡隔增厚、中性粒细胞浸润等,血清中炎症因子IL-6、IL-1β和内皮细胞因子VEGF、ESM-1含量均升高(P＜0.05),肺组织中胞间连接蛋白F-actin、VE-cadherin、ZO-1表达降低,H3Cit蛋白表达升高(P＜0.05),GSK484治疗可以有效改善这些变化.LPS诱导肺微血管内皮细胞上清中炎症因子表达量升高、内皮细胞因子VEGF、ESM-1含量均升高(P＜0.05),细胞成管能力降低;2.5 μmol/L浓度GSK484处理可降低炎症因子和内皮细胞因子表达(P＜0.05).结论 GSK484的使用可有效抑制脓毒症后H3Cit表达,进一步改善脓毒症后内皮功能障碍的发生. |
|---|---|
| AbstractList | 目的 探讨PAD4抑制剂(GSK484)对脓毒症后H3Cit表达的抑制作用,并探究其对脓毒症引起的内皮功能障碍的改善效果.方法 C57BL/6小鼠18只通过盲肠结扎穿孔术(CLP)构建小鼠脓毒症模型,实验分为假手术组,模型组和GSK484治疗组,6只/组,治疗组在术后第2天腹腔注射给予GSK484(4mg/kg).ELISA检测小鼠血清VEGF、ESM-1、IL-6、IL-1β水平,HE染色观察肺组织病理学变化,免疫荧光和Western blotting检测各组小鼠肺组织中F-actin、VE-cadherin、ZO-1蛋白表达,Western blotting检测肺组织VE-Cadherin和H3Cit蛋白表达情况.肺组织原代分离培养肺微血管内皮细胞,使用脂多糖(LPS,10 μg/mL)干预24 h构建脓毒症模型.检测细胞成管能力,CCK-8检测细胞增殖,流式检测细胞凋亡,ELISA检测细胞上清中VEGF、ESM-1、IL-6、IL-1β水平.结果 与假手术组相比,脓毒症小鼠肺组织肺脏血管充血、肺泡断裂、肺泡腔及肺间质水肿、肺泡隔增厚、中性粒细胞浸润等,血清中炎症因子IL-6、IL-1β和内皮细胞因子VEGF、ESM-1含量均升高(P＜0.05),肺组织中胞间连接蛋白F-actin、VE-cadherin、ZO-1表达降低,H3Cit蛋白表达升高(P＜0.05),GSK484治疗可以有效改善这些变化.LPS诱导肺微血管内皮细胞上清中炎症因子表达量升高、内皮细胞因子VEGF、ESM-1含量均升高(P＜0.05),细胞成管能力降低;2.5 μmol/L浓度GSK484处理可降低炎症因子和内皮细胞因子表达(P＜0.05).结论 GSK484的使用可有效抑制脓毒症后H3Cit表达,进一步改善脓毒症后内皮功能障碍的发生. |
| Abstract_FL | Objective To investigate the inhibitory effect of GSK484,a PAD4 inhibitor,on H3Cit expression following sepsis and its effects for improving sepsis-induced endothelial dysfunction.Methods Eighteen C57BL/6 mice were randomized into sham-operated group,sepsis model group and GSK484 treatment group(n=6),and in the latter two groups,models of sepsis were established by cecal ligation and puncture(CLP).The mice in GSK484 treatment group were given an intraperitoneal injection of GSK484(4 mg/kg)on the second day following the surgery.Twenty-four hours after the injection,the mice were euthanized for measurement of serum levels of VEGF,ESM-1,IL-6 and IL-1β using ELISA.Lung tissue pathology was observed with HE staining,and pulmonary expressions of F-actin,VE-cadherin,ZO-1 and H3Cit proteins were detected using immunofluorescence staining and Western blotting.In primary cultured of mouse lung microvascular endothelial cells,the effect of stimulation with LPS(10 μg/mL)for 24 h on tube formation,proliferation,apoptosis and expressions of VEGF,ESM-1,IL-6 and IL-1β were assessed using CCK-8 assay,flow cytometry and ELISA.Results Compared to the sham-operated mice,the septic mice exhibited significant lung tissue pathologies characterized by vascular congestion,alveolar rupture,edema,and neutrophil infiltration.Serum levels of IL-6,IL-1β,VEGF,and ESM-1 were elevated,pulmonary expressions of F-actin,VE-cadherin,and ZO-1 were decreased,and H3Cit expression was increased significantly in the septic mice.GSK484 treatment effectively mitigated these changes in the septic mice.The LPS-stimulated endothelial cells showed increased productions of IL-6,IL-1β,VEGF and ESM-1,which were significantly reduced after treatment with 2.5 pmol/L GSK484.Conclusion GSK484 treatment effectively suppresses H3Cit expression in septic mice to ameliorate sepsis-induced endothelial dysfunction. |
| Author | 戴靖榕 肖宝 金子琦 苏晓飞 李霖 刘斌 |
| AuthorAffiliation | 中南大学湘雅医学院附属长沙医院//长沙市第一医院急诊科,湖南长沙 410005%中南大学湘雅医学院附属长沙医院//长沙市第一医院全科医学科,湖南长沙 410005 |
| AuthorAffiliation_xml | – name: 中南大学湘雅医学院附属长沙医院//长沙市第一医院急诊科,湖南长沙 410005%中南大学湘雅医学院附属长沙医院//长沙市第一医院全科医学科,湖南长沙 410005 |
| Author_FL | DAI Jingrong LI Lin XIAO Bao JIN Ziqi SU Xiaofei LIU Bin |
| Author_FL_xml | – sequence: 1 fullname: SU Xiaofei – sequence: 2 fullname: LI Lin – sequence: 3 fullname: DAI Jingrong – sequence: 4 fullname: XIAO Bao – sequence: 5 fullname: JIN Ziqi – sequence: 6 fullname: LIU Bin |
| Author_xml | – sequence: 1 fullname: 苏晓飞 – sequence: 2 fullname: 李霖 – sequence: 3 fullname: 戴靖榕 – sequence: 4 fullname: 肖宝 – sequence: 5 fullname: 金子琦 – sequence: 6 fullname: 刘斌 |
| BookMark | eNo9kM1KAlEAhe_CIDPfok2Lme7f_C3FSiOhoFrLvc7cUGKEpkh3YZolmFlBMARWtGhVrVqU2st0netbZBitDnwHvgNnDsT8su8BsICgjjDCeKmkF4PA15FpEY1ig-oYYjrpJiQG4v94FiSDoMihgYgFDRPGgdhMLdNRqyvP3uV5LbO1Tm06Pg7VV3MKsyRdPFAPz2o4lM2OGnzKt864f6_q16PXq-i2qWofo3bvu_8kLy_kaSMKX2Srp04G4_AuemxHYV12utFNbx7MCLYXeMm_TICd1ZXtdFbLbWTW0qmcFiBILQ07lEFS8Bj1DIaxKxinyOQcQu64ApvM5tRwoGszw7ExLthM2J7rWYSYBLKCIAmwOPUeMV8wfzdfKh_u-5PFvFstVd1Khf8egzBEFvkBvZx7kA |
| ContentType | Journal Article |
| Copyright | Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
| Copyright_xml | – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
| DBID | 2B. 4A8 92I 93N PSX TCJ |
| DOI | 10.12122/j.issn.1673-4254.2024.12.16 |
| DatabaseName | Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) |
| DatabaseTitleList | |
| DeliveryMethod | fulltext_linktorsrc |
| DocumentTitle_FL | GSK484,a PAD4 inhibitor,improves endothelial dysfunction in mice with sepsis-induced lung injury by inhibiting H3Cit expression |
| EndPage | 2403 |
| ExternalDocumentID | dyjydxxb202412017 |
| GrantInformation_xml | – fundername: (长沙市自然科学基金项目); (睿意急诊医学研究专项基金) funderid: (长沙市自然科学基金项目); (睿意急诊医学研究专项基金) |
| GroupedDBID | --- 2B. 4A8 92F 92I 93N ABJNI ACGFS ALMA_UNASSIGNED_HOLDINGS CW9 F5P PSX RPM TCJ TGQ U1G U5O |
| ID | FETCH-LOGICAL-s1047-294a03cea4e5a22dfab416bb00b9df26a8b4590d8a59822c8af8ede733630acf3 |
| ISSN | 1673-4254 |
| IngestDate | Thu May 29 04:08:05 EDT 2025 |
| IsPeerReviewed | false |
| IsScholarly | true |
| Issue | 12 |
| Keywords | 肺损伤 小鼠肺微血管内皮细胞 PAD4抑制剂 lung injury 内皮功能障碍 脓毒症 GSK484 endothelial dysfunction sepsis mouse pulmonary microvascular endothelial cells PAD4 inhibitor |
| Language | Chinese |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-s1047-294a03cea4e5a22dfab416bb00b9df26a8b4590d8a59822c8af8ede733630acf3 |
| PageCount | 8 |
| ParticipantIDs | wanfang_journals_dyjydxxb202412017 |
| PublicationCentury | 2000 |
| PublicationDate | 2024 |
| PublicationDateYYYYMMDD | 2024-01-01 |
| PublicationDate_xml | – year: 2024 text: 2024 |
| PublicationDecade | 2020 |
| PublicationTitle | 南方医科大学学报 |
| PublicationTitle_FL | Journal of Southern Medical University |
| PublicationYear | 2024 |
| Publisher | 中南大学湘雅医学院附属长沙医院//长沙市第一医院急诊科,湖南长沙 410005%中南大学湘雅医学院附属长沙医院//长沙市第一医院全科医学科,湖南长沙 410005 |
| Publisher_xml | – name: 中南大学湘雅医学院附属长沙医院//长沙市第一医院急诊科,湖南长沙 410005%中南大学湘雅医学院附属长沙医院//长沙市第一医院全科医学科,湖南长沙 410005 |
| SSID | ssib051370560 ssib006562552 ssj0002923145 ssib002263520 ssib001186833 |
| Score | 2.4118063 |
| Snippet | 目的 探讨PAD4抑制剂(GSK484)对脓毒症后H3Cit表达的抑制作用,并探究其对脓毒症引起的内皮功能障碍的改善效果.方法 C57BL/6小鼠18只通过盲肠结扎穿孔术(CLP)构建小鼠脓毒症... |
| SourceID | wanfang |
| SourceType | Aggregation Database |
| StartPage | 2396 |
| Title | PAD4抑制剂GSK484通过抑制H3Cit表达减轻小鼠脓毒症肺损伤后内皮功能障碍的发生 |
| URI | https://d.wanfangdata.com.cn/periodical/dyjydxxb202412017 |
| Volume | 44 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAQN databaseName: PubMed Central (WRLC) issn: 1673-4254 databaseCode: RPM dateStart: 20170101 customDbUrl: isFulltext: true dateEnd: 99991231 titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ omitProxy: true ssIdentifier: ssj0002923145 providerName: National Library of Medicine |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw3R1Na9RANNQWxIsoKn5TpHOSrdlJJpk5TvbDoiiCLfRW8rHx47CC3ULbk9RqtVBrVRAWoSoePFVPHrStf8Z0t__C9172I90tUj0KIQzvvXmfk8l7k2RiGCOcu0EYhVauEguZs33pwDXH8cKDHClSoekEWCjeuOmMTdjXJsXkwNBG5q2lmVowGs7v-13Jv0QVYBBX_Er2LyLbYQoAaEN84QwRhvOBYnxLF21WcpjUTOVZSTApmedQQzHJr96-bksgUPQ6g2YlwJYZVP99Xcaswr0a4nWeaUmEJTwQ7zJZJkiReR5CPJMginkFpk1EgRBlIVddZoqzksuUS3IAxZmnSWCRKehlUy8b-Sjgk4oArKBemukUookYulsoF2QBShWQRnNklRJL4gPKoCkAATX2vKZI2CIqAwooh3mKIAUyBFi5LR-APtDGRpFpJ9MgP2nRHpWkkUfWAz9FRiumLaZKXRLAFMkwhRorJ4tBZ1NAgEQRf5Ci9vLnhBHoCVXMLsrw7nIs-VGill0L-80gg5UkeR65uGN8h0ahHeDTtJE61MuDQQQROGCQD0dst3u7Fy_jsS-lR6aglwt4pArDOOxngn4xwcs0_sro8U5seKFthZOxtFfcZRsfHwnGxf_lF4G64eWYGaq9ev6TpzKZiONaObih2tlUJd0qtT0l82ziYbXGc5rE4i6b-yZIkKlyypBQyGhHyCgOYnwuku_Zl54y3Wju_lw0OxsgUR4qBveQMcRdyOx7Vkfz-O8NK1seQDmTKUcdXG0RnXJK5C3XbC_PYObMsdqk_8p3FDtsjLTVvvIHpemTy2rsV-9kqoPxY8bRVlk_rNM5-rgxMH_3hBHj_LyzvJY8-5Y8X0hn491H9ebPpRRIs27zw-fm9naytNrc-pF8Xd3dfN9cfL3z5VXj7VJz4fvOyvqvzU_JyxfJ0yeN-kayvN58vLVbf9f4uNKoLyara4036yeNiXJpvDCWa_3XJjedboyjbN-0wopvV4TPeRT7AZTFATgoUFHMHV8GtlBmJH3aXTWUfiwrUQU3rrVMP4ytU8Zg9UG1ctoYDqFiU1z4gRvFUI7gj-BCUzoxlMGhsMP4jHGp5Zep1n1reqovmmcPQnTOOILtdPX5vDFYezhTuQD1WC24SIPgN09rHEc |
| linkProvider | National Library of Medicine |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=PAD4%E6%8A%91%E5%88%B6%E5%89%82GSK484%E9%80%9A%E8%BF%87%E6%8A%91%E5%88%B6H3Cit%E8%A1%A8%E8%BE%BE%E5%87%8F%E8%BD%BB%E5%B0%8F%E9%BC%A0%E8%84%93%E6%AF%92%E7%97%87%E8%82%BA%E6%8D%9F%E4%BC%A4%E5%90%8E%E5%86%85%E7%9A%AE%E5%8A%9F%E8%83%BD%E9%9A%9C%E7%A2%8D%E7%9A%84%E5%8F%91%E7%94%9F&rft.jtitle=%E5%8D%97%E6%96%B9%E5%8C%BB%E7%A7%91%E5%A4%A7%E5%AD%A6%E5%AD%A6%E6%8A%A5&rft.au=%E8%8B%8F%E6%99%93%E9%A3%9E&rft.au=%E6%9D%8E%E9%9C%96&rft.au=%E6%88%B4%E9%9D%96%E6%A6%95&rft.au=%E8%82%96%E5%AE%9D&rft.date=2024&rft.pub=%E4%B8%AD%E5%8D%97%E5%A4%A7%E5%AD%A6%E6%B9%98%E9%9B%85%E5%8C%BB%E5%AD%A6%E9%99%A2%E9%99%84%E5%B1%9E%E9%95%BF%E6%B2%99%E5%8C%BB%E9%99%A2%2F%2F%E9%95%BF%E6%B2%99%E5%B8%82%E7%AC%AC%E4%B8%80%E5%8C%BB%E9%99%A2%E6%80%A5%E8%AF%8A%E7%A7%91%2C%E6%B9%96%E5%8D%97%E9%95%BF%E6%B2%99+410005%25%E4%B8%AD%E5%8D%97%E5%A4%A7%E5%AD%A6%E6%B9%98%E9%9B%85%E5%8C%BB%E5%AD%A6%E9%99%A2%E9%99%84%E5%B1%9E%E9%95%BF%E6%B2%99%E5%8C%BB%E9%99%A2%2F%2F%E9%95%BF%E6%B2%99%E5%B8%82%E7%AC%AC%E4%B8%80%E5%8C%BB%E9%99%A2%E5%85%A8%E7%A7%91%E5%8C%BB%E5%AD%A6%E7%A7%91%2C%E6%B9%96%E5%8D%97%E9%95%BF%E6%B2%99+410005&rft.issn=1673-4254&rft.volume=44&rft.issue=12&rft.spage=2396&rft.epage=2403&rft_id=info:doi/10.12122%2Fj.issn.1673-4254.2024.12.16&rft.externalDocID=dyjydxxb202412017 |
| thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fdyjydxxb%2Fdyjydxxb.jpg |